Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMMUNIC, INC.IMUX · Entity 6306 | Chief Financial Officer | July 22, 2019 | July 25, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMMUNIC, INC.
Report date July 22, 2019 · Filed July 25, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.63 · Expires 2029-07-22 | Direct | 79,891 |
Reported balance
After 2019-07-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-07-22 · Grant · Acquired 79,891 · Balance 79,891 F1: 19,987 of the options vest on the one-year anniversary of the grant date. Thereafter, 1,664 of the options vest on the thirteen (13) month anniversary of the grant date, and 1,664 of the options vest on each successive one-month anniversary thereafter for the next thirty five (35) months. |
Filing footnotes · ownership attribution and instrument terms
F1: 19,987 of the options vest on the one-year anniversary of the grant date. Thereafter, 1,664 of the options vest on the thirteen (13) month anniversary of the grant date, and 1,664 of the options vest on each successive one-month anniversary thereafter for the next thirty five (35) months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2019 Filed Jul 25, 2019 01:00 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 79,891 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0001193805-19-000673 · e618568_4-sanjay.xml · derivative · entry 1 Patel Sanjay S · CIK 0001611708 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,891 Underlying: Common Stock · 79,891 shares Expires 2029-07-22 F1 · derivative.exercise_date: 19,987 of the options vest on the one-year anniversary of the grant date. Thereafter, 1,664 of the options vest on the thirteen (13) month anniversary of the grant date, and 1,664 of the options vest on each successive one-month anniversary thereafter for the next thirty five (35) months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.